A randomised controlled trial to evaluate the clinical and cost effectiveness of the Stroke Action Falls rehabilitation programme compared to usual care alone to reduce falls in stroke survivors
Stroke
The study is investigating whether the SAF programme compiling of a checklist, action plan and supporting materials (such as training) can reduce falling in patients who are discharged to their home after a stroke. The SAF programme is being tested as part of the FISS trial which is taking place in stroke services across the UK. Patients will be introduced to the study either in hospital or shortly after discharge, and those who are interested in taking part will be asked to provide consent. Due to the patient population and the challenges some patients face after stroke, consent can be provided written/electronically by the patient, verbally by the patient (witnessed by friend, healthcare professional etc) or provided by a personal consultee. Following consent, but before randomisation, information about the participant will be collected such as their demographic details, information on their stroke and any previous falls and they will be asked to complete questionnaires (these will be asked by a healthcare professional in person or over the phone). Participants will be randomised into one of two groups: SAF plus usual care or usual care alone. Neither the participant, or any other stroke service staff can choose which group each participant is allocated to, this is decided randomly. Participants randomised to the usual care group will receive the same post-stroke care they would receive if they hadn't joined the trial, and this will be in line with local NHS stroke service practice. Participants who are randomised to SAF plus usual care, will receive the NHS service post-stroke care plus will be contacted by their local Falls Lead to complete the SAF programme. The SAF programme comprises of a minimum of three sessions with the potential for a fourth triggered session should a participant fall or move home. The sessions take place as follows: Session 1 (2 weeks after randomisation)- in person at participants home (where possible) – the Falls Lead and participan
1. Aged 18 years or over 2. Confirmed stroke diagnosis in hospital 3. Planned to be discharged to home, (including sheltered accommodation, somebody else's home) 4. Able to report number of falls and complete questionnaires either individually or via a carer/family member/personal consultee 5. Ability to provide informed consent from participant or an advice form from Personal consultee
1. Resident of, or being discharged to a care home 2. And/or on end-of-life pathway